Idarubicin hydrochloride Injection 5 mg in 5 mL (2)

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

idarubicin hydrochloride, Quantity: 1 mg/mL

Commercializzato da:

Pfizer (Perth) Pty Ltd

Forma farmaceutica:

Injection, solution

Composizione:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Via di somministrazione:

Intravenous Infusion

Confezione:

1 X 5 mL

Tipo di ricetta:

(S1) This Schedule is intentionally blank

Indicazioni terapeutiche:

Idamycin PFS Injection in combination with other approved anti leukemic drugs is indicated for the treatment of acute myeloid leukemia (AML) in adults. This includes the French-American-British (FAB) classifications M1 through M7.

Dettagli prodotto:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution.; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Listed (Export Only)

Data dell'autorizzazione:

2019-05-03